tert-Butyl (2R,4R)-4-fluoro-2-(hydroxymethyl)pyrrolidine-1-carboxylate, 95.0%, 250mg

4-(Difluoromethyl)-1,2-difluorobenzene, 97.0%, 25g

Oxion Inverso OX.2053-PLPH con objetivos LWD Plan fase 10x/20x/40x y mesa cruzada XY

7-fluoro-2H-indazole-5-carboxylic acid, 97%, 1g

3,4-DICHLORO-2,5-DIHYDRO-1H-PYRROLE-2,5-DIONE, 95.0%, 1g

6-Methoxypyrido[3,4-d]pyrimidin-4(3H)-one, 98.41%, 250mg

5-Fluoro-2-(6-fluoro-2-methyl-1H-benzo[d]imidazol-1-yl)-N4-(4-(trifluoromethyl)phenyl)pyrimidine-4,6-diamine, 98.0%, 25mg

3,5-Dibromosalicylic acid, 95.0%, 100g

Tamis de test Ø 200 mm, 0,6 mm, 1 Pièce(s)

1-(2-Phenoxy-ethyl)-piperidine, 95.0%, 1g

2-(Phenylthio)acetaldehyde, 95%, 1g

Standard Mixture of Fatty Acid Methyl Esters (consists of Methyl Hexanoate, Heptanoate, Octanoate, Nonanoate, and Decanoate) [Standard Material for GC]5mL

Methyl Myristate [Standard Material for GC]>99.5%(GC)5mL